Kuniaki Saito Selected Research

Kuniaki Saito Research Topics

Disease

23	Neoplasms (Cancer) 01/2024 - 03/2008
14	Inflammation (Inflammations) 09/2022 - 01/2002
13	Infections 11/2021 - 01/2003
10	Glioma (Gliomas) 05/2021 - 03/2008
6	COVID-19 12/2023 - 09/2020
6	Lymphoma (Lymphomas) 11/2021 - 05/2008
6	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 03/2008
5	Carcinogenesis 11/2021 - 03/2010
4	Shock 01/2023 - 01/2012
4	Cognitive Dysfunction 01/2023 - 05/2008
4	Major Depressive Disorder (Major Depressive Disorders) 09/2022 - 01/2020
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 04/2010
4	Ischemia 03/2009 - 06/2005
3	Body Weight (Weight, Body) 01/2024 - 06/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 11/2021
3	Sepsis (Septicemia) 01/2023 - 11/2014
3	Schizophrenia (Dementia Praecox) 11/2022 - 01/2019
3	Colitis 03/2020 - 09/2005
3	Oligodendroglioma 01/2019 - 03/2008
3	Brain Neoplasms (Brain Tumor) 01/2017 - 01/2008
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 05/2015
3	Fibrosis (Cirrhosis) 01/2016 - 01/2013
3	Hepatitis 09/2014 - 02/2009
3	Brain Ischemia (Cerebral Ischemia) 03/2009 - 06/2005
3	Atherosclerosis 05/2005 - 04/2003
2	Hypertension (High Blood Pressure) 01/2024 - 01/2023
2	Septic Shock (Toxic Shock Syndrome) 01/2023 - 10/2018
2	Lewis Lung Carcinoma 06/2022 - 10/2019
2	Neurodevelopmental Disorders 02/2022 - 09/2019
2	Seizures (Absence Seizure) 02/2022 - 04/2012
2	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 01/2016
2	Chronic Hepatitis C 11/2021 - 01/2016
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 09/2019
2	Autism Spectrum Disorder 02/2020 - 09/2019
2	Mania (Manias) 02/2020 - 01/2020
2	Carcinoma (Carcinomatosis) 05/2018 - 10/2010
2	Myocarditis (Carditis) 01/2017 - 04/2012
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016 - 03/2005
2	Viral Encephalitis 04/2015 - 04/2014
2	Virus Diseases (Viral Diseases) 04/2015 - 01/2013
2	Massive Hepatic Necrosis 09/2014 - 01/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2010 - 03/2006

Drug/Important Bio-Agent (IBA)

24	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 11/2023 - 02/2008
23	Messenger RNA (mRNA)IBA 12/2023 - 01/2003
22	Tryptophan (L-Tryptophan)FDA Link 03/2021 - 02/2002
21	CytokinesIBA 01/2022 - 04/2003
20	KynurenineIBA 03/2021 - 02/2002
15	EnzymesIBA 11/2021 - 01/2003
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 04/2002
10	Proteins (Proteins, Gene)FDA Link 03/2020 - 01/2006
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2013
6	ProgranulinsIBA 11/2021 - 10/2014
5	Immunoglobulin G (IgG)IBA 12/2023 - 09/2020
5	LipopolysaccharidesIBA 01/2023 - 02/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2006
4	Glycoproteins (Glycoprotein)IBA 11/2021 - 10/2014
4	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 11/2021 - 01/2017
4	InterferonsIBA 10/2019 - 02/2004
4	ChemokinesIBA 01/2017 - 03/2010
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 03/2005
3	3-hydroxykynurenineIBA 01/2021 - 12/2010
3	AntigensIBA 01/2021 - 10/2004
3	Rituximab (Mabthera)FDA Link 09/2020 - 04/2010
3	Vincristine (Oncovin)FDA LinkGeneric 09/2020 - 04/2011
3	AntibodiesIBA 09/2020 - 03/2010
3	sym-trinitrobenzeneIBA 03/2020 - 09/2005
3	Interleukin-10 (Interleukin 10)IBA 03/2020 - 09/2013
3	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 04/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 04/2011
3	LipidsIBA 06/2017 - 01/2004
3	NF-kappa B (NF-kB)IBA 09/2005 - 03/2005
2	Cisplatin (Platino)FDA LinkGeneric 06/2023 - 05/2023
2	Phencyclidine (Angel Dust)IBA 11/2022 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 09/2022 - 03/2006
2	Glutamic Acid (Glutamate)FDA Link 02/2022 - 07/2007
2	VaccinesIBA 01/2022 - 11/2021
2	BNT162 VaccineIBA 01/2022 - 11/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021 - 01/2021
2	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 03/2021 - 10/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 03/2012
2	fosfestrol (Kyorin)FDA Link 01/2021 - 09/2020
2	Methotrexate (Mexate)FDA LinkGeneric 09/2020 - 05/2008
2	Interleukin-17 (Interleukin 17)IBA 08/2020 - 01/2019
2	Imiquimod (Aldara)FDA LinkGeneric 08/2020 - 04/2015
2	Sulfates (Sulfates, Inorganic)IBA 03/2020 - 09/2013
2	LithiumIBA 02/2020 - 01/2020
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 02/2020 - 01/2020
2	Kynurenic Acid (Kynurenate)IBA 01/2020 - 01/2019
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 10/2011
2	1-methyltryptophanIBA 08/2015 - 09/2013
2	Temozolomide (Temodar)FDA LinkGeneric 01/2014 - 03/2008
2	Surface Antigens (Surface Antigen)IBA 08/2012 - 01/2003
2	InterleukinsIBA 04/2012 - 01/2006

Therapy/Procedure

12	Therapeutics 01/2023 - 03/2008
7	Drug Therapy (Chemotherapy) 11/2021 - 05/2008
5	Radiotherapy 01/2017 - 03/2008
3	Aftercare (After-Treatment) 06/2022 - 10/2010
3	Craniotomy 05/2021 - 02/2009
2	Immunotherapy 01/2023 - 03/2021